Apple: Steve Jobs' Liver Transplant


CNBC's Jim Goldman takes a look at how Apple's stock is reacting to news that the company's CEO had a liver transplant two months and expects to return to Apple at the end of June.

Show commentsHide Comments

Latest Markets Videos

Search Stock Quotes
Commodity Prices
Video Archives
Partner Videos